Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2a, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With a Major Depressive Episode Associated With Bipolar II Disorder

NCT06429722 is registered in ClinicalTrials.gov with Neumora Therapeutics, Inc. as lead sponsor.

NCT NCT06429722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06429722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2a, Randomized, Double-blind, Placebo-controlled Pilot Study to Evaluate the Effects of Oral NMRA-335140 Versus Placebo in Participants With a Major Depressive Episode Associated With Bipolar II Disorder
Lead sponsor
Neumora Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 13, 2024
Completion date
May 30, 2025
Enrollment
18 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive episode associated with bipolar ii disorder